Historique
Détail de l'auteur
Documents disponibles écrits par cet auteur (6)
Ajouter le résultat à votre sélection Affiner la recherche
M. R. LOFWALL ; J. MARTIN ; M. TIERNEY ; M. FATSEAS ; M. AURIACOMBE ; N. LINTZERIS | 2014
Dans Journal of Addiction Medicine (Vol.8, n°5, September-October 2014) Article : PériodiqueThis case is an amalgamation of several real patients in office-based treatment for prescription opioid dependence synthesized into a single theoretical case. The case illustrates the various ways in which medication diversion and misuse may be [...]
ENGLISH : The aging "baby boomer" population has higher rates of substance use than previous cohorts and is predicted to put increased demands on substance abuse treatment services; however; little is known about older illicit drug abusers. Th[...]
S. L. WALSH ; S. D. COMER ; M. R. LOFWALL ; B. VINCE ; N. LEVY-COOPERMAN ; D. KELSH ; M. A. COE ; J. D. JONES ; P. A. NUZZO ; F. TIBERG ; B. SHELDON ; S. KIM | 2017
Dans JAMA Psychiatry (Vol.74, n°9, September 2017) Article : PériodiqueImportance: Buprenorphine is an efficacious, widely used treatment for opioid use disorder (OUD). Daily oral transmucosal formulations can be associated with misuse, diversion, and nonadherence; these limitations may be obviated by a sustained r[...]
M. R. LOFWALL ; M. J. WUNSCH ; P. A. NUZZO ; S. L. WALSH | 2011
Dans Journal of Substance Abuse Treatment (Vol.41, n°3, October 2011) Article : PériodiqueAs office-based opioid dependence treatment (OBOT) has grown in the United States, postmarketing surveillance data reveal increased reports of buprenorphine misuse and diversion, it is important that doctors understand buprenorphine clinical pha[...]
M. R. LOFWALL ; S. L. WALSH | 2014
Dans Journal of Addiction Medicine (Vol.8, n°5, September-October 2014) Article : PériodiqueOutpatient opioid addiction treatment with sublingual buprenorphine pharmacotherapy has rapidly expanded in the United States and abroad, and, with this increase in medication availability, there have been increasing concerns about its diversion[...]
L. S. MIDDLETON ; P. A. NUZZO ; M. R. LOFWALL ; D. E. MOODY ; S. L. WALSH | 2011
Dans Addiction (Vol.106, n°8, August 2011) Article : PériodiqueAIMS Sublingual buprenorphine and buprenorphine/naloxone are efficacious opioid dependence pharmacotherapies, but there are reports of their diversion and misuse by the intranasal route. The study objectives were to characterize and compare thei[...]
